NASDAQ: SKYE
Skye Bioscience Inc Stock Ownership - Who owns Skye Bioscience?

Insider buying vs selling

Have Skye Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
5am Partners VII LLC10% Owner2025-08-22163,979$3.42
$560.81kSell
5am Partners VII LLC10% Owner2025-08-226,470$3.42
$22.13kSell
Andrew J. SchwabDirector2025-08-22163,979$3.42
$560.81kSell
Andrew J. SchwabDirector2025-08-226,470$3.42
$22.13kSell
Andrew J. SchwabDirector2025-08-2158,642$3.57
$209.35kSell
5am Partners VII LLC10% Owner2025-08-212,314$3.57
$8.26kSell
5am Partners VII LLC10% Owner2025-08-2158,642$3.57
$209.35kSell
Andrew J. SchwabDirector2025-08-212,314$3.57
$8.26kSell

1 of 1

SKYE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SKYE insiders and whales buy or sell their stock.

SKYE Shareholders

What type of owners hold Skye Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Versant Ventures III LLC1,565.71%501,925,802$547.10MInsider
Emerald Health Sciences Inc528.45%169,407,901$184.65MInsider
5am Venture Management LLC30.20%9,681,763$10.55MInstitution
Andrew J. Schwab30.20%9,681,763$10.55MInsider
5am Partners VII LLC30.20%9,681,763$10.55MInsider
Cosmas N. Lykos14.35%4,599,400$5.01MInsider
Reg Alexander Lapham11.81%3,787,500$4.13MInsider
Versant Venture Management LLC6.26%2,007,704$2.19MInstitution
Richard D. Squires4.68%1,500,000$1.64MInsider
Baker Bros Advisors LP4.53%1,450,638$1.58MInstitution

1 of 3

SKYE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SKYE2.73%97.27%Net Selling
RNXT19.45%11.51%Net BuyingNet Buying
VERU6.39%93.61%Net Buying
XLO38.83%61.17%Net Buying
GBIO12.03%87.97%Net BuyingNet Selling

Skye Bioscience Stock Ownership FAQ

Who owns Skye Bioscience?

Skye Bioscience (NASDAQ: SKYE) is owned by 62.02% institutional shareholders, 2,208.28% Skye Bioscience insiders, and 0.00% retail investors. Versant Ventures III LLC is the largest individual Skye Bioscience shareholder, owning 501.93M shares representing 1,565.71% of the company. Versant Ventures III LLC's Skye Bioscience shares are currently valued at $542.08M.

If you're new to stock investing, here's how to buy Skye Bioscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.